Epic AI Boosts Cancer Detection to 69%

Epic's Art AI raised lung cancer detection from 46% to 69% at Advocate Health — the EHR-integrated AI story that every health system needs to hear

69% vs 46%. That's not a typo. That's what happens when AI meets EHR data at scale.

Epic's Art AI — an artificial intelligence platform built directly into the Epic EHR — raised early lung cancer detection rates from 46 percent to 69 percent at Advocate Health, one of the largest health systems in the country. The result was published in peer-reviewed literature and represents one of the most compelling real-world AI clinical outcomes studies published in 2026.

📊 The 23 percentage point improvement in early detection is clinically significant in a way that translates directly into survival outcomes. For lung cancer, stage at diagnosis is the primary determinant of survival. Early-stage lung cancer — stage I and II — is surgically resectable with five-year survival rates above 60 percent. Late-stage lung cancer carries survival rates below 15 percent at five years. Every patient who moves from late-stage to early-stage diagnosis because of better detection has materially better survival…